Flanders (BE2)


Flanders has showcased as a region with great potential in the pharmaceutical market. The region is characterised by exceptionally rapid approval times for clinical trials and puts heavy emphasis on biotech R&D, through a well-developed ecosystem of startups, SMEs and larger international companies. Different strategic research centra (VIB, imec, VITO) focus on aspects related to personalised medicine and work on the valorisation of their research.


Personalised medicine is furthermore one of the priorities in Flanders' smart specialisation strategy. In this light, Flanders is one of the leading regions in the smart specialisation partnership on personalised medicine (S3P4PM) and coordinator of the SAPHIRe project.

Policy document (RIS3): Yes

Policy document PM@RIS3: Yes

If you would like to add your region to the Observatory please complete the survey here

Image attribution

By Blank map of Europe (with disputed regions).svg: maix¿?derivative work: Alphathon - This file was derived from:  Blank map of Europe (with disputed regions).svg:, CC BY-SA 3.0, https://commons.wikimedia.org/w/index.php?curid=27466561


This project has received funding from the European Union’s Horizon 

2020 research and innovation programme under grant agreement No 825046

The project is co-ordinated by Department Economy, Science and Innovation (EWI) of the Flemish Government.

Department Economy, Science and Innovation - Koning Albert II-laan 35 1030 Brussels, Belgium